| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 1.36e-05 | 85 | 126 | 6 | GO:0032092 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | ZDHHC2 RELN VPS18 PDE4A RAPSN RASGRF2 WNT5A CKAP5 GRIN2A GRM5 NCDN STXBP1 PLCB1 SLC7A10 | 5.48e-05 | 663 | 126 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | ZDHHC2 RELN VPS18 PDE4A RAPSN RASGRF2 WNT5A CKAP5 GRIN2A GRM5 NCDN STXBP1 PLCB1 SLC7A10 | 5.57e-05 | 664 | 126 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | positive regulation of binding | 8.47e-05 | 170 | 126 | 7 | GO:0051099 | |
| GeneOntologyBiologicalProcess | sensory perception | OR5P3 CABP1 CABP2 PDE4A DHRS3 OR52L1 RDH10 GRIN2A REST OR2T10 OPRL1 OR6A2 OR52N2 OR2D3 PLCB2 GJA10 OR10G8 CRB2 | 9.08e-05 | 1072 | 126 | 18 | GO:0007600 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 9.41e-05 | 233 | 126 | 8 | GO:0050806 | |
| MousePheno | syndactyly | 3.62e-06 | 93 | 97 | 7 | MP:0000564 | |
| Domain | EGF | PCSK5 VLDLR FRAS1 RELN VWDE EGFL6 FBN2 FCGBP MEGF6 NOTCH3 CRB2 | 5.65e-07 | 235 | 126 | 11 | SM00181 |
| Domain | EGF-like_dom | PCSK5 VLDLR FRAS1 RELN VWDE EGFL6 FBN2 FCGBP MEGF6 NOTCH3 CRB2 | 9.99e-07 | 249 | 126 | 11 | IPR000742 |
| Domain | hEGF | 3.57e-05 | 28 | 126 | 4 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 5.01e-05 | 97 | 126 | 6 | IPR018097 | |
| Domain | EGF_CA | 5.61e-05 | 99 | 126 | 6 | PS01187 | |
| Domain | EGF_1 | 5.88e-05 | 255 | 126 | 9 | PS00022 | |
| Domain | ASX_HYDROXYL | 5.94e-05 | 100 | 126 | 6 | PS00010 | |
| Domain | EGF-like_CS | 7.03e-05 | 261 | 126 | 9 | IPR013032 | |
| Domain | EGF_2 | 7.90e-05 | 265 | 126 | 9 | PS01186 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.23e-05 | 106 | 126 | 6 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 9.12e-05 | 156 | 126 | 7 | IPR009030 | |
| Domain | EF-hand_like | 1.29e-04 | 15 | 126 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.29e-04 | 15 | 126 | 3 | PF00387 | |
| Domain | PLCYc | 1.29e-04 | 15 | 126 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.29e-04 | 15 | 126 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.29e-04 | 15 | 126 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 1.29e-04 | 15 | 126 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.29e-04 | 15 | 126 | 3 | IPR015359 | |
| Domain | REELIN | 1.35e-04 | 3 | 126 | 2 | PS51019 | |
| Domain | PLC-beta_C | 1.35e-04 | 3 | 126 | 2 | PF08703 | |
| Domain | Reeler_dom | 1.35e-04 | 3 | 126 | 2 | IPR002861 | |
| Domain | PLC-beta_C | 1.35e-04 | 3 | 126 | 2 | IPR014815 | |
| Domain | Reeler | 1.35e-04 | 3 | 126 | 2 | PF02014 | |
| Domain | Post-SET_dom | 1.57e-04 | 16 | 126 | 3 | IPR003616 | |
| Domain | PostSET | 1.57e-04 | 16 | 126 | 3 | SM00508 | |
| Domain | POST_SET | 1.57e-04 | 16 | 126 | 3 | PS50868 | |
| Domain | EGF_CA | 1.79e-04 | 122 | 126 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.95e-04 | 124 | 126 | 6 | IPR001881 | |
| Domain | EGF_3 | 1.96e-04 | 235 | 126 | 8 | PS50026 | |
| Domain | PI-PLC-X | 2.27e-04 | 18 | 126 | 3 | PF00388 | |
| Domain | PLCXc | 2.27e-04 | 18 | 126 | 3 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 2.68e-04 | 19 | 126 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 2.68e-04 | 19 | 126 | 3 | IPR000909 | |
| Domain | PLC-beta | 2.69e-04 | 4 | 126 | 2 | IPR016280 | |
| Domain | Ca-bd_2 | 2.69e-04 | 4 | 126 | 2 | IPR015754 | |
| Domain | EGF_CA | 2.90e-04 | 86 | 126 | 5 | PF07645 | |
| Domain | AWS | 4.46e-04 | 5 | 126 | 2 | SM00570 | |
| Domain | AWS | 4.46e-04 | 5 | 126 | 2 | PS51215 | |
| Domain | AWS_dom | 4.46e-04 | 5 | 126 | 2 | IPR006560 | |
| Domain | Fringe-like | 4.46e-04 | 5 | 126 | 2 | IPR003378 | |
| Domain | Fringe | 4.46e-04 | 5 | 126 | 2 | PF02434 | |
| Domain | - | 6.19e-04 | 25 | 126 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 6.19e-04 | 25 | 126 | 3 | IPR017946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 7.49e-05 | 12 | 101 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 7.49e-05 | 12 | 101 | 3 | M47628 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.04e-04 | 151 | 101 | 7 | M19428 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.43e-04 | 70 | 101 | 5 | M8232 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.43e-04 | 70 | 101 | 5 | M3115 | |
| Pathway | WP_GPR40_PATHWAY | 1.53e-04 | 15 | 101 | 3 | M39526 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.53e-04 | 71 | 101 | 5 | MM14491 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.87e-04 | 16 | 101 | 3 | MM14699 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.79e-04 | 48 | 101 | 4 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.79e-04 | 48 | 101 | 4 | MM14589 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 3.99e-04 | 134 | 101 | 6 | M3574 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.64e-04 | 90 | 101 | 5 | M6467 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDE4A RASGRF2 WNT5A WNT2B HCAR1 OBSCN TSHB GRM5 OPRL1 PPP2CA PPP2CB CXCR6 PLCB1 PLCB2 | 4.66e-04 | 702 | 101 | 14 | M746 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.98e-04 | 22 | 101 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.98e-04 | 22 | 101 | 3 | M47675 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 5.01e-04 | 5 | 101 | 2 | M27759 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 5.01e-04 | 5 | 101 | 2 | MM15504 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.70e-04 | 23 | 101 | 3 | M47676 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 6.48e-04 | 24 | 101 | 3 | M751 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 7.48e-04 | 6 | 101 | 2 | M47548 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 7.86e-04 | 101 | 101 | 5 | M39387 | |
| Pathway | KEGG_MELANOGENESIS | 7.86e-04 | 101 | 101 | 5 | M7761 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 7.86e-04 | 101 | 101 | 5 | MM15829 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 8.23e-04 | 26 | 101 | 3 | M27053 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 8.35e-04 | 59 | 101 | 4 | MM15838 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 9.47e-04 | 61 | 101 | 4 | M152 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.03e-03 | 28 | 101 | 3 | MM14711 | |
| Pathway | PID_REELIN_PATHWAY | 1.03e-03 | 28 | 101 | 3 | M69 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.04e-03 | 7 | 101 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.04e-03 | 7 | 101 | 2 | M22049 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.04e-03 | 7 | 101 | 2 | M26992 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 1.04e-03 | 7 | 101 | 2 | M47505 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.06e-03 | 108 | 101 | 5 | M17034 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.10e-03 | 289 | 101 | 8 | MM15057 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 CPAMD8 SLC16A9 DHRS3 UACA CARMIL1 SHB ASH1L RDH10 OBSCN AHCYL2 PLD3 CDC42BPB NCDN NIT2 OPRL1 ARFGEF3 ATP2C1 MEGF6 XPNPEP3 EP300 NOTCH3 | 2.60e-08 | 1489 | 128 | 22 | 28611215 |
| Pubmed | PCSK5 CABP1 DNAH10 NSD1 CDC42BPB ADAMTS12 PPP2CA ATP2C1 KCNH2 CPNE3 PLCB1 PLCB2 ATP1A1 EP300 PLXNA1 | 8.65e-08 | 730 | 128 | 15 | 34857952 | |
| Pubmed | KDM5A SHB ASH1L HKDC1 AHCYL2 LYST RYR2 CHUK ADAMTS12 PPP2CA PPP2CB MFNG STXBP1 ATP1A1 OR10G8 PLCH1 ZBTB11 DNAH6 VARS1 FCMR | 3.31e-07 | 1442 | 128 | 20 | 35575683 | |
| Pubmed | PDE4A UACA ZNRD2 KDM5A SH3GL2 CKAP5 NSD1 GRIN2A GRM5 CDC42BPB NCDN PPP2CB WDR45 KLHL7 PLCB1 DNMT1 | 5.45e-07 | 963 | 128 | 16 | 28671696 | |
| Pubmed | 2.24e-06 | 57 | 128 | 5 | 18022353 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE PCSK5 FRAS1 PDE4A SPEG RDH10 OBSCN NSD1 LYST CDC42BPB PPP2CB MEGF6 KCNH2 HMGXB3 EP300 PLXNA1 | 3.23e-06 | 1105 | 128 | 16 | 35748872 |
| Pubmed | mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. | 4.02e-06 | 9 | 128 | 3 | 30214040 | |
| Pubmed | VLDLR RELN KDM5A PEG3 ASH1L CKAP5 CDC42BPB CHUK SETDB1 STXBP1 TTC7B KLHL7 ZBTB11 VARS1 EP300 SEZ6L DNMT1 | 5.16e-06 | 1285 | 128 | 17 | 35914814 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 6.59e-06 | 33 | 128 | 4 | 26864203 | |
| Pubmed | Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway. | 1.05e-05 | 12 | 128 | 3 | 11719201 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 1.30e-05 | 39 | 128 | 4 | 19010793 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 1.34e-05 | 2 | 128 | 2 | 2555176 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12363388 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11751260 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15937072 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28232491 | ||
| Pubmed | Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. | 1.34e-05 | 2 | 128 | 2 | 32683896 | |
| Pubmed | PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. | 1.34e-05 | 2 | 128 | 2 | 11224545 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19525236 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11113010 | ||
| Pubmed | Structure and expression of Wnt13, a novel mouse Wnt2 related gene. | 1.34e-05 | 2 | 128 | 2 | 9545553 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15185077 | ||
| Pubmed | Cholesterol regulates HERG K+ channel activation by increasing phospholipase C β1 expression. | 1.34e-05 | 2 | 128 | 2 | 23793622 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10543450 | ||
| Pubmed | Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. | 1.34e-05 | 2 | 128 | 2 | 24395787 | |
| Pubmed | Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non‑small cell lung cancer. | 1.34e-05 | 2 | 128 | 2 | 36102318 | |
| Pubmed | Lack of CaBP1/Caldendrin or CaBP2 Leads to Altered Ganglion Cell Responses. | 1.34e-05 | 2 | 128 | 2 | 27822497 | |
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 1.34e-05 | 2 | 128 | 2 | 34902541 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 1.34e-05 | 2 | 128 | 2 | 2837763 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23775084 | ||
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 1.34e-05 | 2 | 128 | 2 | 1846293 | |
| Pubmed | Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling. | 1.34e-05 | 2 | 128 | 2 | 20007903 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 1.34e-05 | 2 | 128 | 2 | 27096707 | |
| Pubmed | Functions of CaBP1 and CaBP2 in the peripheral auditory system. | 1.34e-05 | 2 | 128 | 2 | 29661613 | |
| Pubmed | RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes. | 1.34e-05 | 2 | 128 | 2 | 27000652 | |
| Pubmed | Common genetic variation and the control of HIV-1 in humans. | 1.44e-05 | 40 | 128 | 4 | 20041166 | |
| Pubmed | 2.11e-05 | 407 | 128 | 9 | 12693553 | ||
| Pubmed | 2.32e-05 | 45 | 128 | 4 | 25979088 | ||
| Pubmed | 3.82e-05 | 18 | 128 | 3 | 1979339 | ||
| Pubmed | Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. | 4.02e-05 | 3 | 128 | 2 | 23209795 | |
| Pubmed | A unique fold of phospholipase C-beta mediates dimerization and interaction with G alpha q. | 4.02e-05 | 3 | 128 | 2 | 11753430 | |
| Pubmed | DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. | 4.02e-05 | 3 | 128 | 2 | 15671176 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 26195764 | ||
| Pubmed | Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. | 4.02e-05 | 3 | 128 | 2 | 12364493 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18778775 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19850892 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 35652101 | ||
| Pubmed | Role of members of the Wnt gene family in human hematopoiesis. | 4.02e-05 | 3 | 128 | 2 | 9787155 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 39430242 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 7510677 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28100769 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 10380917 | ||
| Pubmed | B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation. | 4.02e-05 | 3 | 128 | 2 | 15632055 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28123028 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11920707 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27151458 | ||
| Pubmed | Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. | 4.02e-05 | 3 | 128 | 2 | 12670700 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 26048293 | ||
| Pubmed | p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. | 4.02e-05 | 3 | 128 | 2 | 19275888 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23651034 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33128264 | ||
| Pubmed | Functional importance of covalent homodimer of reelin protein linked via its central region. | 4.02e-05 | 3 | 128 | 2 | 21844191 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 21521618 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23083738 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 4.02e-05 | 3 | 128 | 2 | 8206937 | |
| Pubmed | Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. | 4.02e-05 | 3 | 128 | 2 | 12071960 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19129398 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23478264 | ||
| Pubmed | Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair. | 4.02e-05 | 3 | 128 | 2 | 38147128 | |
| Pubmed | Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections. | 4.02e-05 | 3 | 128 | 2 | 23758727 | |
| Pubmed | ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. | 4.02e-05 | 3 | 128 | 2 | 21976526 | |
| Pubmed | Reelin and its receptors, VLDLR and ApoER2, in melanocytic nevi. | 4.02e-05 | 3 | 128 | 2 | 28255385 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33998651 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 4.02e-05 | 3 | 128 | 2 | 23341017 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8383590 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15252037 | ||
| Pubmed | INTS6L PCSK5 DDR1 ZCCHC9 UACA CARMIL1 ASH1L OBSCN NSD1 RPP14 OPRL1 FBN2 TSTD2 EP300 ACOXL | 4.27e-05 | 1215 | 128 | 15 | 15146197 | |
| Pubmed | VPS18 CARMIL1 CKAP5 GRIN2A PLD3 GRM5 CDC42BPB NCDN PPP2CB STXBP1 TTC7B SPON1 ATP1A1 PLCH1 DNAH6 VARS1 | 7.56e-05 | 1431 | 128 | 16 | 37142655 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | L3MBTL2 DHX37 CARMIL1 SH3GL2 SHB CKAP5 NCDN FBN2 MAST4 KLHL7 CPNE3 ATP1A1 | 7.74e-05 | 853 | 128 | 12 | 28718761 |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 34425033 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 16481437 | ||
| Pubmed | Disabled1 regulates the intracellular trafficking of reelin receptors. | 8.02e-05 | 4 | 128 | 2 | 15718228 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 9753089 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 14724251 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 17548821 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 26708384 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 21454489 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10330164 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 16129692 | ||
| Pubmed | Structural basis for specific recognition of reelin by its receptors. | 8.02e-05 | 4 | 128 | 2 | 20223215 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 17442808 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 11978185 | ||
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 8.02e-05 | 4 | 128 | 2 | 21998041 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10571240 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10571241 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 9188725 | ||
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 8.02e-05 | 4 | 128 | 2 | 7616230 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 9920888 | ||
| Pubmed | Expression and regulation of reelin and its receptors in the enteric nervous system. | 8.02e-05 | 4 | 128 | 2 | 24844606 | |
| Interaction | IGFL3 interactions | 3.54e-07 | 75 | 122 | 7 | int:IGFL3 | |
| Interaction | H2BC9 interactions | FRAS1 DNAH10 ASH1L CKAP5 NSD1 HKDC1 REST CDC42BPB PREX2 EGFL6 ZBTB11 DNAH6 DNMT1 | 3.16e-06 | 446 | 122 | 13 | int:H2BC9 |
| Interaction | SHANK3 interactions | VPS18 SH3GL2 CKAP5 GRIN2A GRM5 CDC42BPB NCDN ARFGEF3 PPP2CA MEGF6 PLCB1 VARS1 NOTCH3 | 9.93e-06 | 496 | 122 | 13 | int:SHANK3 |
| Interaction | NTN5 interactions | 1.24e-05 | 24 | 122 | 4 | int:NTN5 | |
| Cytoband | 12q24.31 | 7.74e-05 | 80 | 128 | 4 | 12q24.31 | |
| GeneFamily | Phospholipases | 6.87e-05 | 42 | 95 | 4 | 467 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.28e-04 | 19 | 95 | 3 | 832 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.47e-04 | 34 | 95 | 3 | 487 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.05e-03 | 13 | 95 | 2 | 693 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | VLDLR DDR1 SLC16A9 SPEG SH3GL2 PEG3 ASH1L LYST VWDE RRAGC PPP2CB STXBP1 MAST4 TTC7B KCNH2 PLCB1 | 1.41e-05 | 946 | 127 | 16 | M39169 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 2.27e-05 | 313 | 127 | 9 | M40228 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_DN | 2.32e-05 | 117 | 127 | 6 | M9403 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.92e-05 | 196 | 127 | 7 | M3008 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP | 5.42e-05 | 199 | 127 | 7 | M3084 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN | 5.59e-05 | 200 | 127 | 7 | M6366 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 5.59e-05 | 200 | 127 | 7 | M5168 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | DDR1 IFT140 FRAS1 VPS18 DHRS3 SPEG PEG3 WNT2B RDH10 LYST ATP2C1 MEGF6 PLCB1 CRB2 PHLPP2 | 6.17e-05 | 955 | 127 | 15 | M45680 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 8.44e-06 | 23 | 122 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.57e-09 | 191 | 128 | 9 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.26e-09 | 198 | 128 | 9 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.26e-09 | 198 | 128 | 9 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-07 | 198 | 128 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.84e-07 | 179 | 128 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-07 | 182 | 128 | 7 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-06 | 186 | 128 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 186 | 128 | 7 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 187 | 128 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-06 | 187 | 128 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-06 | 190 | 128 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-06 | 190 | 128 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-06 | 192 | 128 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 192 | 128 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-06 | 193 | 128 | 7 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.51e-06 | 194 | 128 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-06 | 194 | 128 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-06 | 195 | 128 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 195 | 128 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 196 | 128 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 197 | 128 | 7 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 197 | 128 | 7 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-06 | 198 | 128 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-06 | 198 | 128 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.12e-06 | 146 | 128 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.54e-06 | 169 | 128 | 6 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 171 | 128 | 6 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.02e-05 | 171 | 128 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 171 | 128 | 6 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 172 | 128 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 172 | 128 | 6 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 174 | 128 | 6 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 175 | 128 | 6 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 128 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.20e-05 | 176 | 128 | 6 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.28e-05 | 178 | 128 | 6 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 180 | 128 | 6 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 180 | 128 | 6 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 180 | 128 | 6 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 180 | 128 | 6 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-05 | 181 | 128 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.41e-05 | 181 | 128 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-05 | 182 | 128 | 6 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 182 | 128 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-05 | 183 | 128 | 6 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.59e-05 | 185 | 128 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.69e-05 | 187 | 128 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 187 | 128 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 187 | 128 | 6 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-05 | 187 | 128 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 188 | 128 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 188 | 128 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 188 | 128 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.80e-05 | 189 | 128 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 189 | 128 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 1.80e-05 | 189 | 128 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.80e-05 | 189 | 128 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 189 | 128 | 6 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 190 | 128 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 190 | 128 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 190 | 128 | 6 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-05 | 191 | 128 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 191 | 128 | 6 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.91e-05 | 191 | 128 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 191 | 128 | 6 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.91e-05 | 191 | 128 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 191 | 128 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 128 | 6 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.97e-05 | 192 | 128 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.97e-05 | 192 | 128 | 6 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.03e-05 | 193 | 128 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 194 | 128 | 6 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 194 | 128 | 6 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-05 | 195 | 128 | 6 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.15e-05 | 195 | 128 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-05 | 195 | 128 | 6 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 195 | 128 | 6 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-05 | 195 | 128 | 6 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.15e-05 | 195 | 128 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 195 | 128 | 6 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 195 | 128 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 195 | 128 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.21e-05 | 196 | 128 | 6 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-05 | 197 | 128 | 6 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 2.27e-05 | 197 | 128 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 198 | 128 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-05 | 198 | 128 | 6 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.34e-05 | 198 | 128 | 6 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 198 | 128 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 198 | 128 | 6 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-05 | 199 | 128 | 6 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 199 | 128 | 6 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| Drug | Diethylstilbestrol | VLDLR DDR1 RELN DHRS3 WNT5A WNT2B TSHB AHCYL2 PLD3 TIPARP TFF2 CHUK FBN2 FCGBP CXCR6 KCNH2 SPON1 PLCB1 NNT SLC7A10 VARS1 EP300 DNMT1 | 7.13e-07 | 1305 | 126 | 23 | ctd:D004054 |
| Disease | idiopathic pulmonary fibrosis (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:0050156 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.84e-05 | 195 | 123 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Schizophrenia | VLDLR DDR1 RELN PDE4A GRIN2A REST GRM5 ADAMTS12 SETDB1 STXBP1 KCNH2 PLCB1 SLC7A10 DNMT1 | 1.96e-05 | 883 | 123 | 14 | C0036341 |
| Disease | Bipolar Disorder | 3.27e-05 | 477 | 123 | 10 | C0005586 | |
| Disease | schizophrenia (is_marker_for) | 3.43e-05 | 44 | 123 | 4 | DOID:5419 (is_marker_for) | |
| Disease | Colorectal Carcinoma | ZDHHC2 CPAMD8 VPS18 RASGRF2 PEG3 OBSCN GRIN2A PREX2 NCDN GTF2B FBN2 EP300 | 3.88e-05 | 702 | 123 | 12 | C0009402 |
| Disease | prostate cancer (is_marker_for) | 5.06e-05 | 156 | 123 | 6 | DOID:10283 (is_marker_for) | |
| Disease | lymphocyte count | FRAS1 PDE4A RAPSN DNAH10 NSD1 HKDC1 REST PLD3 LYST PREX2 OPRL1 GTF2B PLCB1 SLC7A10 VARS1 ACOXL DNMT1 | 1.24e-04 | 1464 | 123 | 17 | EFO_0004587 |
| Disease | West Syndrome | 1.34e-04 | 24 | 123 | 3 | C0037769 | |
| Disease | ICAM-1 measurement | 1.34e-04 | 24 | 123 | 3 | EFO_0004520 | |
| Disease | neutrophil count | VLDLR CPAMD8 RAPSN ASH1L NSD1 TSHB REST PREX2 EGFL6 RRAGC DCUN1D2 PLCB1 PLCB2 ATP1A1 ACOXL DNMT1 | 2.06e-04 | 1382 | 123 | 16 | EFO_0004833 |
| Disease | Vestibular Diseases | 3.57e-04 | 7 | 123 | 2 | C0042594 | |
| Disease | Morphine Abuse | 3.57e-04 | 7 | 123 | 2 | C0600272 | |
| Disease | Morphine Dependence | 3.57e-04 | 7 | 123 | 2 | C0026552 | |
| Disease | retinal detachment, retinal break | 4.20e-04 | 35 | 123 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | HbA1c measurement | CPAMD8 B3GLCT RAPSN CARMIL1 ASH1L HKDC1 ITGAD OPRL1 OR52N2 PLCB1 | 5.43e-04 | 675 | 123 | 10 | EFO_0004541 |
| Disease | myeloid white cell count | VLDLR RAPSN DNAH10 HKDC1 REST PREX2 RRAGC PLCB1 PLCB2 ATP1A1 ACOXL DNMT1 | 5.59e-04 | 937 | 123 | 12 | EFO_0007988 |
| Disease | Neurodevelopmental Disorders | 6.30e-04 | 93 | 123 | 4 | C1535926 | |
| Disease | platelet crit | VLDLR PDE4A RAPSN IP6K3 CARMIL1 REST RPP14 ITGAD MAST4 PLCB1 SLC7A10 NOTCH3 | 6.43e-04 | 952 | 123 | 12 | EFO_0007985 |
| Disease | cardiovascular disease | 6.79e-04 | 457 | 123 | 8 | EFO_0000319 | |
| Disease | alopecia areata (is_marker_for) | 7.59e-04 | 10 | 123 | 2 | DOID:986 (is_marker_for) | |
| Disease | age at onset, multiple sclerosis | 7.59e-04 | 10 | 123 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | HIV-1 infection | 7.68e-04 | 98 | 123 | 4 | EFO_0000180 | |
| Disease | response to statin, myopathy | 9.25e-04 | 11 | 123 | 2 | EFO_0004145, GO_0036273 | |
| Disease | Long QT Syndrome | 9.25e-04 | 11 | 123 | 2 | C0023976 | |
| Disease | cryptic phenotype measurement | 1.00e-03 | 47 | 123 | 3 | EFO_0021487 | |
| Disease | IGF-1 measurement | 1.04e-03 | 488 | 123 | 8 | EFO_0004627 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0800544 | |
| Disease | autistic disorder (is_marker_for) | 1.11e-03 | 12 | 123 | 2 | DOID:12849 (is_marker_for) | |
| Disease | response to fenofibrate | 1.20e-03 | 50 | 123 | 3 | GO_1901557 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.30e-03 | 13 | 123 | 2 | EFO_0800547 | |
| Disease | vascular brain injury measurement, vascular brain injury | 1.30e-03 | 13 | 123 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.54e-03 | 200 | 123 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | delta-6 desaturase measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0007765 | |
| Disease | FEV/FEC ratio | PCSK5 FRAS1 IP6K3 ZNRD2 SPEG SHB NSD1 REST FCGBP TTC7B MEGF6 KLHL7 CRB2 | 1.87e-03 | 1228 | 123 | 13 | EFO_0004713 |
| Disease | Dementia | 2.25e-03 | 17 | 123 | 2 | C0497327 | |
| Disease | C-X-C motif chemokine 16 measurement | 2.52e-03 | 18 | 123 | 2 | EFO_0010911 | |
| Disease | syndrome (implicated_via_orthology) | 2.52e-03 | 18 | 123 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 2.91e-03 | 68 | 123 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | bipolar I disorder | 2.92e-03 | 141 | 123 | 4 | EFO_0009963 | |
| Disease | apolipoprotein A 1 measurement | 2.96e-03 | 848 | 123 | 10 | EFO_0004614 | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.05e-03 | 713 | 123 | 9 | EFO_0005689 | |
| Disease | visceral:subcutaneous adipose tissue ratio | 3.16e-03 | 70 | 123 | 3 | EFO_0004767 | |
| Disease | Manic Disorder | 3.29e-03 | 71 | 123 | 3 | C0024713 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 3.44e-03 | 21 | 123 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | HbA1c measurement, response to sulfonylurea | 3.44e-03 | 21 | 123 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | monocyte count | VLDLR CARMIL1 ASH1L REST LYST PREX2 EGFL6 PLCB1 ATP1A1 SLC7A10 VARS1 ACOXL DNMT1 | 3.48e-03 | 1320 | 123 | 13 | EFO_0005091 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.57e-03 | 243 | 123 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | triacylglycerol 54:8 measurement | 4.12e-03 | 23 | 123 | 2 | EFO_0010426 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 4.12e-03 | 23 | 123 | 2 | DOID:0050156 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMQSLGYCCGRKLEF | 1156 | Q09472 | |
| IRCICGLYKDEGLMI | 2586 | Q9NR48 | |
| ISGRYDCIDINECTM | 211 | Q8IUX8 | |
| CRCYSNDAPDDMVLG | 411 | Q6Y288 | |
| CMYLVVFVCGLVGNS | 36 | O00574 | |
| CLVRMGYQCTFGVLQ | 1286 | P26358 | |
| CCGATAVIMLVGDTY | 371 | Q9NS82 | |
| FLPGVCMYVCVDREA | 506 | Q969M2 | |
| DRVMSVCLRVELYGC | 171 | Q08345 | |
| VECTFLDYIMGGCQL | 276 | O75131 | |
| KDGYINCRDLGNCMR | 241 | Q9NZU7 | |
| IGLCSNRMFCYAVLG | 836 | P98194 | |
| GICKMVGCDYEIDSN | 671 | P58397 | |
| RCLQDCRECTGGMGY | 341 | Q9NUZ1 | |
| VLGATMESRCYGCAV | 71 | Q96K21 | |
| GIDSECINRMLLYEC | 1906 | Q96L73 | |
| YRLLGRLGSAMECCE | 216 | Q13702 | |
| ITQMCEVTGGRSYCV | 196 | Q5JSJ4 | |
| EICMDFLQGTCIYGR | 241 | Q7Z3E1 | |
| LCLCNGLSYEMVGQE | 16 | Q6ZRR7 | |
| CLKQYMQLAIREGCG | 56 | Q7Z419 | |
| ALQRMLVEFYGLDGC | 156 | Q7RTY1 | |
| SCCDYLVGEERQMAE | 61 | Q13127 | |
| GVVMYNCSCLARDLT | 231 | Q8IV08 | |
| TDCLQCMDGYVLQDG | 971 | Q86XX4 | |
| CMDGYVLQDGACVEQ | 976 | Q86XX4 | |
| ARVVACFCEGMTVRG | 271 | P41594 | |
| ACYALMELGIQECTR | 336 | Q9UBB6 | |
| CKVLLDGYLMICVDG | 451 | Q969R5 | |
| LGYAGVTCEMEVDEC | 136 | Q5IJ48 | |
| CVLDGVRGCDSYMVY | 371 | O15111 | |
| ELCCGSVKEMRERYA | 461 | P05023 | |
| DGFCELCGYSRAEVM | 46 | Q12809 | |
| ISGINSMIYCLCSEG | 566 | Q8NDZ0 | |
| MACTQAGERTAIYCL | 16 | Q6PH85 | |
| FECLTVRDYNDMICG | 871 | Q12766 | |
| VRDYNDMICGICGVA | 876 | Q12766 | |
| INCTEGYFMEDGRCV | 801 | Q92824 | |
| GYFMEDGRCVQSCSI | 806 | Q92824 | |
| ENGCLVYNDTTMVCR | 1091 | Q9UIW2 | |
| CVSDYAGGRSLTCIM | 381 | P27815 | |
| ICMAGFTGTYCEVDI | 456 | Q9UM47 | |
| EAELMGRCYLHQCTG | 546 | A0A1B0GTW7 | |
| CSHGMVEANGLIYVC | 421 | Q8IXQ5 | |
| MVGLIRQGYACEVCS | 1046 | Q9Y5S2 | |
| LGGTECFLYRVMSCD | 106 | Q8NGN5 | |
| YGCMTQIIVFLLVGC | 111 | Q8NGH3 | |
| MYIIAVVGNCGLICL | 36 | Q8NGI0 | |
| CYRCGNQAAIMELDD | 266 | P62714 | |
| CYRCGNQAAIMELDD | 266 | P67775 | |
| CLGVRICGMQVYQTD | 246 | Q96PC2 | |
| VDLYVCMFCGRGNNE | 291 | P29375 | |
| TFRPRGMLYECQECG | 961 | Q9GZU2 | |
| AIDNVYIGDGCIDMC | 2471 | P78509 | |
| QLGGAECCLLAAMAY | 106 | Q8NGZ9 | |
| TGRLYDCAAATGMCQ | 61 | Q13349 | |
| QICGLAMADAGEYLC | 3506 | Q5VST9 | |
| AMADAGEYLCVCGQE | 3511 | Q5VST9 | |
| RGLAMADTGEYSCVC | 3596 | Q5VST9 | |
| LVAEDAGEYLCMCGK | 3686 | Q5VST9 | |
| AGEYLCMCGKERTSA | 3691 | Q5VST9 | |
| MLCAGYPEGRRDTCQ | 226 | Q5K4E3 | |
| CVLYAEGQENRCEMT | 751 | Q5K4E3 | |
| GICRLECYESEMLVA | 36 | Q4QY38 | |
| DYTNGRATTCCVMLI | 356 | Q8TED4 | |
| EELGCLVESYGMNVC | 1346 | Q14008 | |
| TDRCYLCLMGALQLD | 1451 | Q9C0G6 | |
| MGTCVYVLAQTCGTR | 1271 | Q9Y6R7 | |
| DFMGTCVYVLAQTCG | 3671 | Q9Y6R7 | |
| MTEACIKGGIEACYA | 411 | Q5TH69 | |
| AKGDGCCLMQIDVTY | 1481 | Q8IZJ3 | |
| ISGYTLRLCKMDNEC | 366 | P03951 | |
| LEGCCGEDIIYMNEN | 1881 | Q99698 | |
| GIYCVGDEVTMADLC | 151 | O43708 | |
| RHLCMVMEYVEGGDC | 641 | O15021 | |
| MYNGSCCRIEGDTIS | 1 | Q9BXC0 | |
| LYEMIVRGSCFCNGH | 256 | A4D0S4 | |
| MVCGALLRGCLQYLA | 381 | Q5VZK9 | |
| VTSFCLGMGARRVCY | 401 | Q8NFI3 | |
| TGRVCLDIRMEQCYL | 991 | P35556 | |
| LNVPGAYRCECEMGF | 1466 | P35556 | |
| MVLLGAVGACEYASC | 856 | Q8IY37 | |
| LLCVVTNCGEGMDYR | 1851 | Q8IVF4 | |
| VRYLAGCGLQSCQML | 2266 | Q92736 | |
| LLEQIADCCMRQGSY | 1191 | Q96RY7 | |
| GYIGCRELGACMRTL | 96 | Q9NPB3 | |
| MGTECHYFICDVGNR | 86 | O75911 | |
| DDCTMGYIIECKLGG | 231 | O00587 | |
| GLGCTECVLLAVMAY | 111 | O95222 | |
| VCVGGLLGNCLVMYV | 61 | P41146 | |
| GVLVAMALDCYVAIC | 131 | Q8NGH7 | |
| GRQCYRIEMEIVNSC | 321 | O75095 | |
| QIMYLGSGLCCVGAL | 621 | Q13423 | |
| ECGTDALRFGLCAYM | 916 | P26640 | |
| CTKLCGGGIQERYMT | 766 | Q9HCB6 | |
| CDMIDVVIDVSCIYG | 286 | Q9HB90 | |
| CYEGFELMGEVTIRC | 901 | Q9BYH1 | |
| GCCAALKAMGSIVYV | 406 | Q96HN2 | |
| LRAMCRLDYCGGSGE | 106 | Q15464 | |
| CEIGLIAGTGSNMCY | 671 | Q2TB90 | |
| RPAGMYLLEGCSCER | 61 | O14827 | |
| CRVGLGICYDMRFAE | 146 | Q9NQR4 | |
| FCCAMETGVRIYNVE | 21 | Q9Y484 | |
| CIILVGMSYLGGCVN | 141 | Q8WZ94 | |
| ILGGVSLNEMRCAYE | 541 | P61764 | |
| VCPYLVDTGMFRGCR | 241 | Q8IZV5 | |
| CGLCLRTMQEIERYL | 631 | Q15047 | |
| VQTARECLIKCMDYG | 911 | Q8IWX7 | |
| GCMGYCAEAISDARL | 151 | Q8N2E2 | |
| CGECGMVFQRRYALI | 571 | O95625 | |
| ECAECGQAFVMGSYL | 331 | Q6ZNH5 | |
| VYLNIGEEGCTCEMN | 1031 | Q6ZVD8 | |
| RRCGAQDAGVYSCMA | 96 | Q15772 | |
| AAMLDCGRDCYAIRV | 166 | Q9H2B4 | |
| DYRAGDMICPECGLV | 26 | Q00403 | |
| SGVQMDQPCCRALYD | 286 | Q99962 | |
| RQMVEAIRYCHGCGV | 116 | Q96PN8 | |
| AAECVYCGELMIRSI | 941 | Q9P253 | |
| GDLIRERSYMCSECG | 231 | Q9Y2P7 | |
| CVMEVSDRRNCGYPG | 81 | Q03403 | |
| IYLCREMAGSGTCGT | 46 | O60667 | |
| CRTREEAMIFGVGLC | 526 | Q70Z35 | |
| VLMYCTGGIRCERGS | 351 | Q5T7W7 | |
| ELMCCGRGYDQFKTV | 336 | P41221 | |
| VEMYRQVLLSGCRCV | 346 | Q9NQ66 | |
| SAEMYRQVLLSGCRC | 341 | Q00722 | |
| MYARVLQEGCRCVEV | 331 | Q4KWH8 | |
| ICAGYCMTRDINGKL | 46 | P01222 | |
| YRMLGETCADCGTIL | 46 | O60232 | |
| RTALMLGCEYGCRDA | 201 | Q9BZF9 | |
| CQDICEGMEYLERNG | 371 | P42681 | |
| IALGRRGQYEMLSEC | 371 | Q86TV6 | |
| EMVLLDGGCESSCYV | 326 | Q9NQH7 | |
| ALENQDMGTGICYRC | 146 | Q8N567 | |
| TMSGAIRYCDRCQLI | 121 | Q9UIJ5 | |
| YMKVCLEFQDCGVGL | 21 | O95059 | |
| EIMCCGRGYDTTRVT | 336 | Q93097 | |
| CSRGYQMDLATGVCK | 421 | P98155 | |
| CDACLRMGNLYDIDE | 1236 | Q12879 |